- Home
- GXO vs LNTH Comparison
GXO vs LNTH Comparison
Compare GXO & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXO
- LNTH
- Stock Information
- Founded
- GXO 2021
- LNTH 1956
- Country
- GXO United States
- LNTH United States
- Employees
- GXO N/A
- LNTH N/A
- Industry
- GXO Transportation Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GXO Consumer Discretionary
- LNTH Health Care
- Exchange
- GXO Nasdaq
- LNTH Nasdaq
- Market Cap
- GXO 4.8B
- LNTH 5.7B
- IPO Year
- GXO N/A
- LNTH 2015
- Fundamental
- Price
- GXO $51.19
- LNTH $55.38
- Analyst Decision
- GXO Buy
- LNTH Strong Buy
- Analyst Count
- GXO 13
- LNTH 6
- Target Price
- GXO $60.62
- LNTH $114.50
- AVG Volume (30 Days)
- GXO 1.0M
- LNTH 1.9M
- Earning Date
- GXO 08-05-2025
- LNTH 08-06-2025
- Dividend Yield
- GXO N/A
- LNTH N/A
- EPS Growth
- GXO N/A
- LNTH N/A
- EPS
- GXO 0.53
- LNTH 3.77
- Revenue
- GXO $12,683,000,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- GXO $10.33
- LNTH $4.57
- Revenue Next Year
- GXO $6.62
- LNTH $9.41
- P/E Ratio
- GXO $95.96
- LNTH $14.54
- Revenue Growth
- GXO 22.39
- LNTH 5.75
- 52 Week Low
- GXO $30.46
- LNTH $47.25
- 52 Week High
- GXO $63.33
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- GXO 55.25
- LNTH 24.74
- Support Level
- GXO $45.75
- LNTH $47.25
- Resistance Level
- GXO $52.28
- LNTH $55.74
- Average True Range (ATR)
- GXO 1.44
- LNTH 2.03
- MACD
- GXO -0.30
- LNTH -1.90
- Stochastic Oscillator
- GXO 70.36
- LNTH 24.97
About GXO GXO Logistics Inc.
GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.